BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30998500)

  • 1. Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated.
    Olzscha H
    Biol Chem; 2019 Jun; 400(7):895-915. PubMed ID: 30998500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When proteostasis goes bad: Protein aggregation in the cell.
    Radwan M; Wood RJ; Sui X; Hatters DM
    IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein folding, misfolding and quality control: the role of molecular chaperones.
    Papsdorf K; Richter K
    Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology].
    Shelkovnikova TA; Kulikova AA; Tsvetkov FO; Peters O; Bachurin SO; Bukhman VL; Ninkina NN
    Mol Biol (Mosk); 2012; 46(3):402-15. PubMed ID: 22888630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways of cellular proteostasis in aging and disease.
    Klaips CL; Jayaraj GG; Hartl FU
    J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein folding and misfolding in the neurodegenerative disorders: a review.
    Bolshette NB; Thakur KK; Bidkar AP; Trandafir C; Kumar P; Gogoi R
    Rev Neurol (Paris); 2014 Mar; 170(3):151-61. PubMed ID: 24613386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein post-translational modifications and misfolding: new concepts in heart failure.
    Del Monte F; Agnetti G
    Proteomics Clin Appl; 2014 Aug; 8(7-8):534-42. PubMed ID: 24946239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
    Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
    Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrinsic and extrinsic factors that contribute to proteostasis decline and pathological protein misfolding.
    Kikis EA
    Adv Protein Chem Struct Biol; 2019; 118():145-161. PubMed ID: 31928724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
    Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
    Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the Role of Normal Aging Processes in the Onset and Pathogenesis of Diseases Associated with the Abnormal Accumulation of Protein Aggregates.
    Ilyinsky NS; Nesterov SV; Shestoperova EI; Fonin AV; Uversky VN; Gordeliy VI
    Biochemistry (Mosc); 2021 Mar; 86(3):275-289. PubMed ID: 33838629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases.
    Pajares M; Cuadrado A; Rojo AI
    Redox Biol; 2017 Apr; 11():543-553. PubMed ID: 28104575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4D imaging of protein aggregation in live cells.
    Spokoini R; Shamir M; Keness A; Kaganovich D
    J Vis Exp; 2013 Apr; (74):. PubMed ID: 23608881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
    Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.